$PHR

Why Phreesia Stock Tumbled Today

Phreesia (PHR) shares fell 6.33% after reporting Q2 2027 revenue of $129.5M, up 10% YoY, and GAAP net income of $1.9M. While revenue beat estimates, earnings per share missed expectations. The company maintained full-year guidance and highlighted recent product launches.

Original reporting
Published Sep 4, 2026, 2:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 3:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Phreesia Stock Tumbled Today — source image
Decision brief

The 30-second read

$PHRBearishMed
01

Why it matters

Earnings miss triggered a 6% decline; guidance remains flat, suggesting limited upside unless new products accelerate.

02

Market read

The earnings release provides fresh data for traders; the stock's price reaction indicates immediate trading relevance.

03

What to watch

New AccessOne financing product and ProviderConnect platform may drive future revenue beyond current guidance.

Relevance 7/10Novelty 7/10Timing: after‑hours

Background

Phreesia is a next‑generation healthcare technology firm that automates patient‑doctor interactions.

Company-level read

Ticker impact

$PHRBearishHigh confidence
Context

Phreesia reported Q2 FY2027 revenue of $129.5M and GAAP net income of $1.9M, missing consensus EPS of $0.09, causing a 6% stock drop.

Expected impact

Further downside pressure if guidance remains unchanged; short‑term bounce possible on any upside surprise.

Evidence & confidence

The miss versus consensus EPS and modest top‑line beat are fresh data; market reaction already shows a 6% decline, indicating sensitivity to earnings.

Market effects

Healthcare tech may see broader scrutiny as earnings miss highlights margin pressure.

U.S. small‑cap healthcare tech segment could face slight pullback.

Limited to investors tracking digital health providers.

Counterpoint

If the restructuring yields cost savings, the stock could rebound on the back of long‑term growth potential.

Key entities

  • Phreesia

    Healthcare technology provider reporting Q2 FY2027 results.

Related articles

$PHRMed

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Phreesia (PHR) reported Q2 2027 revenue of $129.5M and adjusted EBITDA of $32.9M, marking five straight quarters of positive net income. Revenue grew 10% YoY, with client count and revenue per client also increasing. The company reduced debt by $23M and credited AI for operational efficiencies. However, management warned of increased unpredictability in network solutions revenue due to financial strain on healthcare providers. Phreesia reaffirmed its full-year revenue and EBITDA guidance.

$PHRHighAI 8/10

Phreesia (PHR) Q2 2027 Earnings Call Transcript

Phreesia (PHR) reported Q2 2027 revenue of $129.5M, up 10% YoY, with adjusted EBITDA of $32.9M and net income of $1.9M. AHSCs grew 6% to 4,744. Full-year guidance: revenue $510M-$520M, adjusted EBITDA $125M-$135M. Management noted variability in revenue forecasting and economic pressures on healthcare providers.

$PHRMed

Why Phreesia Stock Got Knocked Down Today

Phreesia (PHR) stock fell 7% Tuesday due to bearish sentiment after Q2 earnings and a downgrade by Raymond James analyst John Ransom. Ransom cited declining organic revenue growth and AI spending pressures. Despite a 10% revenue increase, concerns remain about future performance and market constraints.

$PHRLow

Phreesia Announces Second Quarter Fiscal 2027 Results

Phreesia, Inc. (PHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Phreesia Announces Second Quarter Fiscal 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del., September 2, 2026 – Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia deli